
About this episode
It was reported on Monday that the University of Oxford developed a coronavirus vaccine that appears safe and triggers an immune response. Another study from King’s College London from the previous week, however, seems to show that immunity to COVID-19 may only last a few months. And the science of developing a vaccine is only one of many hurdles. Once a vaccine is deemed safe and effective, there are many unanswered questions about how to manufacture and fairly distribute it. In this hour, we talk with a panel of experts about where we are in developing a coronavirus vaccine and how a vaccine should be distributed.
Get every episode summarized
Each time KQED's Forum publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from KQED's Forum

What to Expect from a Defiant, Lame-Duck Trump
KQED's Forum
Nov 9, 202052:46pending

Biographer Evan Osnos Describes Unifying Personality in ‘Joe Biden’
KQED's Forum
Nov 9, 202038:14pending

Rep. Barbara Lee on Kamala Harris’ Historic VP Win
KQED's Forum
Nov 9, 202013:29pending

Election 2020: Biden Leads in Georgia and Pennsylvania
KQED's Forum
Nov 6, 202052:47pending